ATI-0918

· Azaya Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATI-0918, covering 2015-01-15 to 2015-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer [Phase 1]

See pricing